Roche Holding AG (0QQ6.L)
0QQ6.L Stock Price Chart
Explore Roche Holding AG interactive price chart. Choose custom timeframes to analyze 0QQ6.L price movements and trends.
0QQ6.L Company Profile
Discover essential business fundamentals and corporate details for Roche Holding AG (0QQ6.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - General
IPO Date
7 Mar 2014
Employees
103.25K
Website
https://www.roche.comCEO
Thomas Schinecker
Description
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD). The company was founded in 1896 and is headquartered in Basel, Switzerland.
0QQ6.L Financial Timeline
Browse a chronological timeline of Roche Holding AG corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 28 Jan 2026
Upcoming earnings on 24 Jul 2025
Revenue estimate is CHF 15.95B.
Dividend declared on 27 Mar 2025
A dividend of CHF 9.70 per share was announced, adjusted to CHF 9.70. The dividend was paid on 31 Mar 2025.
Earnings released on 30 Jan 2025
EPS came in at CHF 2.52 falling short of the estimated CHF 8.40 by -70.00%, while revenue for the quarter reached CHF 30.65B, beating expectations by +100.43%.
Earnings released on 23 Oct 2024
EPS came in at CHF 7.80 falling short of the estimated CHF 9.37 by -16.76%, while revenue for the quarter reached CHF 30.76B, beating expectations by +3.87%.
Earnings released on 26 Apr 2024
EPS came in at CHF 5.42 falling short of the estimated CHF 8.48 by -36.08%, while revenue for the quarter reached CHF 28.94B, missing expectations by -1.11%.
Dividend declared on 14 Mar 2024
A dividend of CHF 9.60 per share was announced, adjusted to CHF 9.60. The dividend was paid on 18 Mar 2024.
Earnings released on 29 Nov 2023
EPS came in at CHF 8.88 falling short of the estimated CHF 10.40 by -14.62%, while revenue for the quarter reached CHF 29.78B, missing expectations by -1.71%.
Dividend declared on 16 Mar 2023
A dividend of CHF 9.50 per share was announced, adjusted to CHF 9.50. The dividend was paid on 20 Mar 2023.
Earnings released on 31 Dec 2022
EPS came in at CHF 4.87 falling short of the estimated CHF 8.78 by -44.53%, while revenue for the quarter reached CHF 30.99B, beating expectations by +0.10%.
Earnings released on 30 Jun 2022
EPS came in at CHF 10.53 falling short of the estimated CHF 11.02 by -4.45%, while revenue for the quarter reached CHF 32.30B, beating expectations by +0.50%.
Dividend declared on 17 Mar 2022
A dividend of CHF 9.30 per share was announced, adjusted to CHF 9.30. The dividend was paid on 21 Mar 2022.
Earnings released on 31 Dec 2021
EPS came in at CHF 7.15 falling short of the estimated CHF 9.74 by -26.59%, while revenue for the quarter reached CHF 32.09B, beating expectations by +0.44%.
Earnings released on 30 Jun 2021
EPS came in at CHF 9.05 falling short of the estimated CHF 10.13 by -10.66%, while revenue for the quarter reached CHF 30.71B, beating expectations by +1.77%.
Dividend declared on 18 Mar 2021
A dividend of CHF 9.10 per share was announced, adjusted to CHF 9.10. The dividend was paid on 22 Mar 2021.
Earnings released on 31 Dec 2020
EPS came in at CHF 7.20 falling short of the estimated CHF 8.81 by -18.27%, while revenue for the quarter reached CHF 29.04B, missing expectations by -3.35%.
0QQ6.L Stock Performance
Access detailed 0QQ6.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.